|
HR24-00001
|
Exploiting host free fatty acids to sterilize Mycobacterium tuberculosis infections
|
Tiago Beites
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
Radboud University
|
Infectious disease
|
HR
Consortium
|
693,011.00
|
|
HR24-00042
|
A new Pathway to Modulate T cell Activity
|
Marc Veldhoen
|
Gulbenkian Institute of Molecular Medicine
|
Associação AccelBio
|
Infectious disease
|
HR
Consortium
|
963,414.00
|
|
HR24-00056
|
Restoring vision by integrating optic nerve organoids in retinitis pigmentosa rat visual circuity
|
Pia Cosma
|
Fundació Centre de Regulació Genòmica (CRG)
|
Universidade do Minho
|
Neuroscience
|
HR
Consortium
|
997,293.00
|
|
HR24-00150
|
Generating stress-resistant β-cell for cell replacement therapy
|
Lorenzo Pasquali
|
Universitat Pompeu Fabra (UPF)
|
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH (Helmholtz Munich)
|
Cardiovascular and associated metabolic diseases
|
HR
Consortium
|
981,616.00
|
|
HR24-00152
|
Generation of humanized organs from human iPS cells
|
Xabier Aranguren
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA)
|
Università degli Studi di Padova and Universidad de Murcia
|
Cardiovascular and associated metabolic diseases
|
HR
Consortium
|
999,127.90
|
|
HR24-00174
|
Peptide-based systems as artificial compartments to diagnose non-Alzheimer Tauopathies diseases
|
Ana Pina
|
Universidade Nova de Lisboa
|
Universitat de Barcelona - Fundació Bosch i Gimpera and Centro Hospitalar Lisboa Occidental
|
Enabling Technologies
|
HR
Consortium
|
999,994.87
|
|
HR24-00279
|
Mapping metastasis plasticity
|
Roger Gomis
|
Fundació Institut de Recerca Biomèdica (IRB Barcelona)
|
Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer
|
Oncology
|
HR
Consortium
|
664,165.90
|
|
HR24-00288
|
Decoding trypanosome interactions with the host vasculature
|
Luisa Figueiredo
|
Gulbenkian Institute of Molecular Medicine
|
Universidade Católica Portuguesa
|
Infectious disease
|
HR
Consortium
|
998,850.00
|
|
HR24-00298
|
Bacteria-based LCOR therapy in lung metastasis and rational design of co-stimulatory molecules
|
Luis Felipe Serrano
|
Fundació Centre de Regulació Genòmica (CRG)
|
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)
|
Enabling Technologies
|
HR
Consortium
|
1,000,000.00
|
|
HR24-00326
|
Engineering the mechanobiology of the immunocompetent tumor ecosystem
|
Xavier Trepat
|
Fundació Institut de Bioenginyeria de Catalunya
|
Fundació Institut de Recerca Biomèdica (IRB Barcelona) and Centre Internacional de Mètodes Numèrics a l'Enginyeria (CIMNE)
|
Enabling Technologies
|
HR
Consortium
|
998,200.00
|
|
HR24-00341
|
LncRNAs modulating DNA damage and repair: towards novel therapies for hepatocellular carcinoma
|
Puri Fortes
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA)
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III and Consejo Superior de Investigaciones Científicas (CSIC)
|
Oncology
|
HR
Consortium
|
999,203.20
|
|
HR24-00445
|
Redox Metabolism as an Achilles’ Heel in Malaria Drug Discovery
|
Ruth Pérez
|
Consejo Superior de Investigaciones Científicas (CSIC)
|
Justus-Liebig-Universität Gießen and Asociación Centro de Investigación Cooperativa en Biociencias-CIC bioGUNE
|
Infectious disease
|
HR
Consortium
|
999,400.00
|
|
HR24-00446
|
Exploring the PERK/STING axis in Pathological Inflammatory Conditions
|
Philippe Pierre
|
Universidade de Aveiro
|
N/A
|
Cardiovascular and associated metabolic diseases
|
HR
Single
Organization
|
499,931.66
|
|
HR24-00447
|
Targeting the Seeds of Relapse in Colorectal Cancer: Residual Disease and the Fibroblast Niche
|
Eduard Batlle
|
Fundació Institut de Recerca Biomèdica (IRB Barcelona)
|
N/A
|
Oncology
|
HR
Single
Organization
|
499,400.00
|
|
HR24-00528
|
Protein Aggregation in the Malaria Parasite: What for?
|
Xavier Fernàndez
|
Fundació Institut de Bioenginyeria de Catalunya
|
Universitat de Barcelona and Nanyang Technological University
|
Infectious disease
|
HR
Consortium
|
907,923.1
|
|
HR24-00578
|
New molecules harnessing targeted protein degradation for the treatment of Machado-Joseph disease
|
Patrícia Maciel
|
Universidade do Minho
|
Universidade do Porto; Ataxia UK and National Ataxia Foundation
|
Neuroscience
|
HR
Consortium
|
999,026.16
|
|
HR24-00581
|
Mitochondrial metabolism, at the heart of disease
|
Guadalupe Sabio
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
Universitat de València; Universidad de Santiago de Compostela and Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)
|
Cardiovascular and associated metabolic diseases
|
HR
Consortium
|
999,920.00
|
|
HR24-00585
|
Development of a Synthetic Viral-like Particle Delivery System for Precision In vivo Gene Therapy
|
Marc Güell
|
Universitat Pompeu Fabra (UPF)
|
N/A
|
Enabling Technologies
|
HR
Single
Organization
|
499,750.00
|
|
HR24-00604
|
Mito4Neuro: Integrative characterization of the mitochondrial DNA replisome in health and disease
|
Rafael Fernandez
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
Hospital 12 de Octubre Research Institute and Fundación IMDEA Nanociencia
|
Neuroscience
|
HR
Consortium
|
900,300.00
|
|
HR24-00641
|
Mechanisms of progression and therapeutic approaches to prevent/reverse MASLD to MASH transition
|
Antonio Vidal
|
Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe
|
Consorcio Centro de Investigación Biomédica en Red
|
Cardiovascular and associated metabolic diseases
|
HR
Consortium
|
999,959.3
|
|
HR24-00648
|
Spatiotemporal dynamics of organ-specific microenvironments in breast cancer metastasis
|
Ana Luisa Correia
|
Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud
|
Tel Aviv University
|
Oncology
|
HR
Consortium
|
997,610.0
|
|
HR24-00672
|
Deep mutational scanning of SOD1 to map mechanisms of toxicity and test novel therapeutics
|
Benedetta Bolognesi
|
Fundació Institut de Bioenginyeria de Catalunya
|
The Royal Melbourne Hospital and University of Wollongong
|
Enabling Technologies
|
HR
Consortium
|
981,070.19
|
|
HR24-00686
|
A High-Resolution Functional Genomics Approach to Inform Precision Medicine for Fungal Disease
|
Agostinho Carvalho
|
Universidade do Minho
|
Radboud university medical center Nijmegen and Fundación Universitaria San Pablo-CEU
|
Infectious diseases
|
HR
Consortium
|
999,898.43
|
|
HR24-00788
|
Brain Inflammation in adrenoleukodystrophy: from drivers to treatments
|
Aurora Pujol
|
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)
|
Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; Universitat de Barcelona and Asociación Española Contra la Leucodistrofia
|
Neuroscience
|
HR
Consortium
|
999,782.47
|
|
HR24-00927
|
Improving Brain Arteriovenous Malformation Cure with local Antioncogenic Nanoparticle Embolization
|
Marc Ribó
|
Fundació Hospital Universitari Vall d´Hebron - Institut de Recerca (VHIR)
|
Universitat de Barcelona; Consorcio Centro de Investigación Biomédica en Red and Fundació Institut Català de Nanociència i Nanotecnologia
|
Neuroscience
|
HR
Consortium
|
998,684.72
|
|
HR24-00929
|
Novel regulators of gamma-delta T cell subset differentiation and activation in infection
|
Bruno Silva-Santos
|
Gulbenkian Institute of Molecular Medicine
|
N/A
|
Infectious disease
|
HR
Single
Organization
|
500,000.00
|
|
HR24-00968
|
Precision ImmuneNanoTherapy targeting tumor-immune-stroma interactions against pancreatic cancer
|
María Jesús Vicent
|
Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe
|
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento and Tel Aviv University
|
Enabling technologies
|
HR
Consortium
|
999,999.4
|
|
HR24-00980
|
DNA topology and topoisomerases during oncogenesis: mechanisms and therapeutic opportunities
|
Felipe Cortés
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
N/A
|
Oncology
|
HR
Single
Organization
|
499,000.00
|
|
HR24-01000
|
Uncovering resistance mechanism to CAR-T cells via deep learning in scRNA-seq for improved therapies
|
Felipe Prosper
|
Universidad de Navarra - Universidad de Navarra
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA) and Weizmann Institute of Science
|
Oncology
|
HR
Consortium
|
991,550.00
|
